EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer

Bei Sun, Zhanhua Gao, Xiyue Liu, Gexue Liu, Shoujun Wang, Jinpu Liu, Junyi Wang, Haiyang Zhang, Mingqing Zhang, Chong Chen, Feng He, Dongzhi Hu und 1 weitere

Frontiers in Public Health · 18.08.2026 · 14

DOI: 10.3389/fpubh.2026.1879297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 18.08.2026. Verfasst von Bei Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Fluorocarbons, Environmental Pollutants. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inroduction Per and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with endocrine-disrupting and carcinogenic potential. However, their bioaccumulation profiles and clinical relevance in human breast cancer remain largely unexplored.

Methods

In this preliminary study we quantified the absolute concentrations of 33 PFAS congeners (ng/g) in paired tumour and adjacent non-tumorous tissues from 11 breast cancer patients ( n = 11) using LC–MS/MS to evaluate their tissue distribution and clinical correlations.

Results

The detection rates for six compounds (HFPOTA, PFOA, PFNA, PFUnDA, PFOS, and 6:2Cl-PFESA) were greater than 40%. In paired samples, several congeners showed higher concentrations in tumour than in adjacent non-tumorous tissue; using a two-sided exact Wilcoxon signed-rank test with Hodges–Lehmann effect sizes, tumour enrichment remained significant after Benjamini–Hochberg correction for HFPOTA ( q = 0.041), PFNA ( q = 0.047) and PFUnDA ( q = 0.047). HFPOTA showed by far the highest tissue burden (median 654 ng/g). Clinically, PFOS concentrations were descriptively higher in Luminal B than in Luminal A tumours and were positively correlated with the proliferation marker Ki-67; a high 6:2Cl-PFESA–PR rank correlation was observed in four samples but was not statistically significant on the raw p-value (p ≈ 0.051) and is exploratory. Bioinformatic analyses indicated that computationally predicted shared target genes of PFAS and breast cancer are enriched in the PPAR signaling pathway, lipid metabolism, and steroid hormone biosynthesis.

Discussion

Collectively, PFAS bioaccumulation was associated with breast cancer clinicopathological characteristics. Because the target genes are predicted rather than experimentally validated and the cohort is small ( n = 11), these are exploratory, hypothesis-generating findings that require validation in larger cohorts. This study underscores the need to reassess the biosafety of novel PFAS alternatives and provides new insights into the environmental etiology of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFluorocarbonsEnvironmental PollutantsHumansFemaleMiddle AgedAgedAdultChromatography, Liquid

Stichwörter der Autor:innen

PFASbioaccumulationbreast cancerclinicopathological characteristicslipid metabolismtumor biomarkers

Substanzen

FluorocarbonsEnvironmental Pollutants

Autor:innen und Institutionen

  • Institute of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
  • Department of Pharmacy, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Zitieren

APA

Sun, B., Gao, Z., Liu, X., Liu, G., Wang, S., Liu, J., Wang, J., Zhang, H., Zhang, M., Chen, C., He, F., Hu, D., & Hao, J. (2026). Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1879297

Vancouver

Sun B, Gao Z, Liu X, Liu G, Wang S, Liu J, et al. Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1879297

BibTeX
@article{Sun2026,
  author = {Sun, Bei and Gao, Zhanhua and Liu, Xiyue and Liu, Gexue and Wang, Shoujun and Liu, Jinpu and Wang, Junyi and Zhang, Haiyang and Zhang, Mingqing and Chen, Chong and He, Feng and Hu, Dongzhi and Hao, Jie},
  title = {Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1879297}
}
Kostenlos starten →